National Accreditation Board Suspends All DNA Testing at D.C. Crime Lab
By Keith L. Alexander,
Washington Post
| 04. 27. 2015
Untitled Document
One of the national organizations that govern DNA laboratories has ordered the District’s new crime lab to immediately suspend all DNA casework after concluding that the lab’s procedures are “insufficient and inadequate.”
D.C. Mayor Muriel E. Bowser ordered the audit by the ANSI-ASQ National Accreditation Board last month after the U.S. attorney’s office said it had discovered numerous errors in some of the lab’s DNA analyses. The audit, which was published Friday, criticized the lab’s practices and said they were not in compliance with FBI standards. It ordered “at a minimum” the revalidation of test procedures, new interpretation guidelines for DNA mixture cases, additional training and competency testing of staff.
The DNA analysts at the District’s Department of Forensic Sciences, according to the audit, “were not competent and were using inadequate procedures.” The authors of the review said the lab must begin to address the concerns within 30 days.
Legal experts say the audit could trigger a further investigation of hundreds of District criminal cases — including murder, sexual assault and gun possession cases — that have involved...
Related Articles
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Elizabeth Dwoskin and Yeganeh Torbati, The Washington Post | 07.16.2025
A group of well-heeled, 30-something women sat down to dinner last spring at a table set with pregnancy-friendly mocktails and orchids, ready to hear a talk about how to optimize their offspring.
Noor Siddiqui, the founder of an embryo-screening start-up...
By Suzanne O'Sullivan, New Scientist | 07.09.2025
Rare diseases are often hard to spot. They can evade detection until irreversible organ damage or disability has already set in. Last month, in the hope of preventing just this type of harm, the UK’s health secretary, Wes Streeting, announced...